Compare BFRI & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFRI | DTSS |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 10.9M |
| IPO Year | 2021 | N/A |
| Metric | BFRI | DTSS |
|---|---|---|
| Price | $0.80 | $1.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 103.6K | 75.7K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $37,164,000.00 | ★ $64,349,277.00 |
| Revenue This Year | $9.70 | N/A |
| Revenue Next Year | $10.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.11 | ★ 68.56 |
| 52 Week Low | $0.54 | $1.03 |
| 52 Week High | $1.87 | $3.10 |
| Indicator | BFRI | DTSS |
|---|---|---|
| Relative Strength Index (RSI) | 39.78 | 38.10 |
| Support Level | $0.77 | $1.08 |
| Resistance Level | $0.83 | $1.66 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 29.89 | 5.98 |
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).